Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1Phase 2 1

Status

Unknown 6Suspended 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

icotinib 1abarelix 1Surgical Procedures, Operative 1Prednisone 1Oxycodone 1Oxaliplatin 1Morphine 1Leucovorin 1Irinotecan 1Fluorouracil 1Fentanyl 1Erlotinib Hydrochloride 1Congresses as Topic 1Clinical Protocols 1Buprenorphine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Suspended × Surgical Procedures, Operative × Clear all
NCT02366819 2026-03-30

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

University of Chicago

Phase 4 Suspended
36 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡